# Excretion Balance, PK and Metabolism of a Single Oral Dose of [14C]PCO371

> **NCT04649216** · PHASE1 · COMPLETED · sponsor: **Chugai Pharmaceutical** · enrollment: 11 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** PCO371
- **DRUG:** [14C]PCO371
- **DRUG:** [14C]PCO371

## Key facts

- **NCT ID:** NCT04649216
- **Lead sponsor:** Chugai Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-25
- **Primary completion:** 2020-12-30
- **Final completion:** 2020-12-30
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2021-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04649216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04649216, "Excretion Balance, PK and Metabolism of a Single Oral Dose of [14C]PCO371". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04649216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*